abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

14 Aug 2019

Author:
Access Now

Letter from Access Now to Novalpina Capital

See all tags

Three months ago, we wrote to both Bulgaria and Cyprus to clarify your statement that “some of NSO's products are exported from the EU (either Bulgaria or Cyprus), where the relevant authorities apply the EU control list (which is based on the Wassenaar control list)" (8). This week, Cypriot authorities responded explaining that they had “not identified the NSO Group to be present in Cyprus and [had] not issued any export licences for NSO Group products.” Considering this is fundamentally a question of Novalpina’s activity in the EU, we ask you for your transparency and cooperation in reconciling these two findings.

... [W]e welcome Novalpina Capital’s affirmation of the UN Guiding Principles on Business and Human Rights (UNGPs) and the UN-supported Principles for Responsible Investment. We are encouraged about your commitment to ensure NSO Group operates in accordance with the UNGPs, including through “robust transparency in line with those Principles"... Specifically we ask that you:

  1. Clarify whether any, and which, NSO Group products, or products of NSO Group subsidiaries, partners, or affiliates, have applied for or been issued export licenses of any kind in Cyprus.
  2. Whether and which NSO Group products, research facilities, subsidiaries, partners, or affiliates are present in Cyprus.